Registration Number
0225U003651,
(0118U004259)
, R & D reports
Title
Development of compositions, technology and biopharmaceutical investigations of pharmacotherapeutical transmucosal delivery systems of medical substances
popup.stage_title
Розробка складу, технології та біофармацевтичні дослідження фармакотерапевтичних систем трансмукозної доставки лікарських речовин
Head
Gladyshev Vitalii V., Доктор фармацевтичних наук
Registration Date
28-07-2025
Organization
Zaporizhzhya State Medical University
popup.description1
popup.description2
The aim of study is development of scientifically reasonable composition and manufacturing technologies of semisolid pharmacotherapeutic medications with antihypertensive and neuroprotective action with vinpocetine and captopril - suppositories and nasal ointments, which have high efficiency and stability, on the basis of research of their physical and chemical, biopharmaceutical, rheologic, microbiological and pharmaco-technological properties. On the basis of complex pharmaco-technological, biopharmaceutical, physical and chemical, rheologic and biological researches the optimal compositions and manufacturing technology of semisolid pharmacotherapeutic medications with vinpocetine and captopril - rectal suppositories and nasal ointments (gel and cream) for therapy of hypertension II - III stages with cardio and cerebrovascular complications have been developed. Scientifically based technological schemes for the production of applicative medications with vinpocetine and captopril have been developed, control parameters of the technological process have been established. Convenient technology of extemporal production of applicative dosage forms with vinpocetine and captopril in the pharmacies have been scientifically based. On a model of acute cerebral circulation by type of ischemic stroke, the pronounced neuroprotective activity of rectal suppositories and nasal cream with vinpocetine was experimentally confirmed and detected, that the effectiveness of data therapy with applicative dosage forms is significantly higher than that compared to oral tablets. On the doxorubicin model of chronic heart failure, the pronounced cardioprotective activity of rectal suppositories and nasal gel with captopril was experimentally confirmed and detected, that the effectiveness of data therapy with applicative dosage forms is significantly higher than that compared to oral tablets. According to the results of the research, they are widely introduced into the practice of pharmacies
Product Description
popup.authors
Al Zedan F.
Biriuk Iryna A.
Burlaka Bohdan S.
Hladysheva Svitlana A.
Kolycheva Nataliia L.
Kurinnyi Anton V.
Lysianska Hanna P.
Lytvynenko Tetiana M.
Maletskyi Mykola M.
Nahornyi Volodymyr V.
Oliinykov Dmytro S.
Pukhalska Iryna O.
Puchkan Liubov O.
Romanina Daria M.
popup.nrat_date
2025-07-28
